GNS HealthcareSomerville, MA, United States
GNS Healthcare (Employment)
Predictors of Effectiveness of First-line Biologic Disease Modifying Antirheumatic Drug(s) (bDMARD) or Targeted Synthetic DMARD (tsDMARD) Treatment with a Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis
Saturday, August 27, 20221:30 PM - 1:35 PM CEST
